BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2026 1:35:08 PM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-20 01:53 |
|
Peer-Review Started |
|
2026-01-20 01:54 |
|
First Decision by Editorial Office Director |
|
2026-02-14 07:48 |
|
Return for Revision |
|
2026-02-14 07:48 |
|
Revised |
|
2026-02-21 14:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-19 02:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-19 09:30 |
|
Articles in Press |
|
2026-03-19 09:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-24 07:07 |
|
Publish the Manuscript Online |
|
2026-06-30 13:35 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Reconsidering the role of metabolic dysfunction-associated steatotic liver disease in pancreatic cancer progression
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan-Ling Li, Dong-Jie Zhang, Ying-Ying Zhu, Chun-Xi Wang and Qing Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chun-Xi Wang, Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Xinmin Street, Changchun 130000, Jilin Province, China. wangchunxi_2020@126.com |
| Key Words |
Pancreatic cancer; Liver metastasis; Metabolic dysfunction-associated steatotic liver disease; Tumor microenvironment; Prognosis |
| Core Tip |
Metabolic dysfunction-associated steatotic liver disease is biologically linked to hepatic inflammation and immune modulation, yet emerging real-world evidence indicates that it is not an independent determinant of liver metastasis or survival in pancreatic cancer. Clinically, metabolic dysfunction-associated steatotic liver disease should be interpreted as a contextual metabolic comorbidity rather than a decisive prognostic factor, avoiding overinterpretation of incidental hepatic steatosis in risk assessment. |
| Publish Date |
2026-06-30 13:35 |
| Citation |
Li YL, Zhang DJ, Zhu YY, Wang CX, Liu Q. Reconsidering the role of metabolic dysfunction-associated steatotic liver disease in pancreatic cancer progression. World J Gastroenterol 2026; 32(25): 119116
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i25/119116.htm |
| DOI |
https://doi.org/10.3748/wjg.119116 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
